Browse our anti-Topoisomerase II alpha (TOP2A) Antibodies

Full name:
anti-Topoisomerase (DNA) II alpha 170kDa Antibodies (TOP2A)
On are 267 Topoisomerase (DNA) II alpha 170kDa (TOP2A) Antibodies from 23 different suppliers available. Additionally we are shipping Topoisomerase II alpha Kits (23) and Topoisomerase II alpha Proteins (3) and many more products for this protein. A total of 295 Topoisomerase II alpha products are currently listed.
D230016L12Rik, TOP-2, TOP2, TOP2A, TP2A
list all antibodies Gene Name GeneID UniProt
TOP2A 21973 Q01320
TOP2A 360243 P41516
TOP2A 7153 P11388

Show all species

Show all synonyms

Most Popular Reactivities for anti-Topoisomerase II alpha (TOP2A) Antibodies

Select your species and application

anti-Mouse (Murine) Topoisomerase II alpha Antibodies:

anti-Rat (Rattus) Topoisomerase II alpha Antibodies:

anti-Human Topoisomerase II alpha Antibodies:

All available anti-Topoisomerase II alpha Antibodies

Go to our pre-filtered search.

Top referenced anti-Topoisomerase II alpha Antibodies

  1. Human Monoclonal Topoisomerase II alpha Primary Antibody for WB - ABIN1109282 : Yoshida, Yamaguchi, Shinagawa, Taira, Nakayama, Miki: Protein kinase C delta activates topoisomerase IIalpha to induce apoptotic cell death in response to DNA damage. in Molecular and cellular biology 2006 (PubMed)
    Show all 8 references for 1109282

  2. Human Monoclonal Topoisomerase II alpha Primary Antibody for IHC (p), IP - ABIN1109281 : Kaplan, Greenlund, Tanner, Shaw, Schreiber: Identification of an interferon-gamma receptor alpha chain sequence required for JAK-1 binding. in The Journal of biological chemistry 1996 (PubMed)
    Show all 7 references for 1109281

  3. Human Polyclonal Topoisomerase II alpha Primary Antibody for EIA, WB - ABIN955291 : Vranic, Frkovic-Grazio, Lamovec, Serdarevic, Gurjeva, Palazzo, Bilalovic, Lee, Gatalica: Adenoid cystic carcinomas of the breast have low Topo IIα expression but frequently overexpress EGFR protein without EGFR gene amplification. in Human pathology 2010 (PubMed)
    Show all 5 references for 955291

  4. Human Polyclonal Topoisomerase II alpha Primary Antibody for ELISA, WB - ABIN1533131 : Lang, Mirski, Cummings, Yu, Gerlach, Cole: Structural organization of the human TOP2A and TOP2B genes. in Gene 1998 (PubMed)

  5. Human Polyclonal Topoisomerase II alpha Primary Antibody for EIA, IF - ABIN955290 : Kawamura, Pope, Christensen, Sun, Terekhova, Boege, Mielke, Andersen, Marko: Mitotic chromosomes are constrained by topoisomerase II-sensitive DNA entanglements. in The Journal of cell biology 2010 (PubMed)

More Antibodies against Topoisomerase II alpha Interaction Partners

Mouse (Murine) Topoisomerase (DNA) II alpha 170kDa (TOP2A) interaction partners

  1. Polyamide functionalisation at the N1-position offers a design strategy to improve drug-like properties. Dicationic HxIP* 3 increased topo IIalpha expression and chemosensitivity to topo II (show TOP2 Antibodies)-targeting agents.

  2. We demonstrated that Nup98 (show NUP98 Antibodies)-TopIIbeta and Nup98 (show NUP98 Antibodies)-SETBP1 (show SETBP1 Antibodies) negatively regulate the XPO1 (show XPO1 Antibodies)-mediated protein export. Our results will contribute to the understanding of the molecular mechanism by which the Nup98 (show NUP98 Antibodies)-fusion proteins induce tumorigenesis.

  3. TOP2 (show TOP2 Antibodies) and BAF (show BANF1 Antibodies) cooperate to recruit pluripotency factors, which explains some of the instructive roles of BAF (show BANF1 Antibodies) complexes.

  4. Deletion or deficiency of PTEN (show PTEN Antibodies) leads to down regulation of TOP2A, dysfunction of the decatenation checkpoint and incomplete DNA decatenation in G2 and M phases.

  5. Inhibition of DNA topoisomerase II (show TOP2 Antibodies) selectively reduces the threat of tumorigenicity

  6. Cohesin removal is a prerequisite for the posterior topoisomerase IIalpha-mediated resolution of persisting catenations between segregating chromatids during anaphase II.

  7. Data show that unfolded protein response (UPR)-induced changes in topoisomerase IIalpha (Topo IIalpha) protein levels are not responsible for resistance to etoposide, and that the PERK plays a Topo IIalpha-independent role in altered sensitivity to the drug.

  8. TOP2beta (show TOP2B Antibodies) as a factor involved in regulating granulosa cell genomic integrity and follicle atresia.

  9. Topoisomerase IIa not only contributes to stem-cell transcriptome regulation but also primes developmental genes for subsequent activation upon differentiation.

  10. studies indicate that the ability of TOP2A to prevent DNA entanglement at mitosis requires BAF (show BANF1 Antibodies) complexes and suggest that this activity contributes to the role of BAF (show BANF1 Antibodies) subunits as tumour suppressors

Human Topoisomerase (DNA) II alpha 170kDa (TOP2A) interaction partners

  1. Tumors with higher topoisomerase IIalpha and/or mitosin (show CENPF Antibodies) expression have a higher risk of recurrence after initial treatment, and these patients may benefit from adjuvant treatment and closer radiological follow-up

  2. Both the genome instability and cell death of MRE11 (show MRE11A Antibodies)-null and MRE11 (show MRE11A Antibodies)-mutated H129N cells are significantly reversed by overexpression of Tdp2 (show TDP2 Antibodies), an enzyme that eliminates covalent Top2 conjugates; thus, the essential role of Mre11 (show MRE11A Antibodies) nuclease (show DCLRE1C Antibodies) activity is likely to remove the DNA lesions.

  3. we show that TopoIIalpha forms protein-protein interactions with beta-catentin and TCF4 (show TCF4 Antibodies) and interacts with Wnt (show WNT2 Antibodies) response elements (WREs) and promoters of direct target genes of TCF (show HNF4A Antibodies) transcription, including: MYC (show MYC Antibodies), vimentin (show VIM Antibodies), AXIN2 (show AXIN2 Antibodies) and LEF1 (show LEF1 Antibodies)

  4. This study shows that both survivin (show BIRC5 Antibodies) and TIIalpha are independent prognostic predictors in human grade II/III astrocytomas stratified for IDH1 (show IDH1 Antibodies)-mutation status

  5. Polyamide functionalisation at the N1-position offers a design strategy to improve drug-like properties. Dicationic HxIP* 3 increased topo IIalpha expression and chemosensitivity to topo II (show TOP2 Antibodies)-targeting agents.

  6. BD ProExtrade mark C assay containing MCM2 (show MCM2 Antibodies) and TOP2A antibodies showed strong specific nuclear staining that correlated with increased cervical dysplasia and lesion severity.

  7. Fbxo28 (show FBXO28 Antibodies) regulates topoisomerase IIalpha decatenation activity and plays an important role in maintaining genomic stability.

  8. TOP2A rs471692 was not associated with chemoradiotherapy response, whereas tumor regression, weight loss, clinical stage, and cigarette smoking were independent prognostic predictors for these Chinese patients with non-small cell lung cancer.

  9. we propose that phosphorylation of TOP2A by CDC7 (show CDC7 Antibodies)/DBF4 (show DBF4 Antibodies) in early S-phase prevents its localization and/or activity at centromeres, and inhibition of TOP2A function could be relevant to prevent premature separation of centromeric DNA.

  10. Data indicate that cortex involvement, lower World Health Organization grade and DNA topoisomerase II (show TOP2 Antibodies) positivity were strong predictors for preoperative epileptic seizures.

Topoisomerase II alpha (TOP2A) Antigen Profile

Antigen Summary

This gene encodes a DNA topoisomerase, an enzyme that controls and alters the topologic states of DNA during transcription. This nuclear enzyme is involved in processes such as chromosome condensation, chromatid separation, and the relief of torsional stress that occurs during DNA transcription and replication. It catalyzes the transient breaking and rejoining of two strands of duplex DNA which allows the strands to pass through one another, thus altering the topology of DNA. Two forms of this enzyme exist as likely products of a gene duplication event. The gene encoding this form, alpha, is localized to chromosome 17 and the beta gene is localized to chromosome 3. The gene encoding this enzyme functions as the target for several anticancer agents and a variety of mutations in this gene have been associated with the development of drug resistance. Reduced activity of this enzyme may also play a role in ataxia-telangiectasia.

Alternative names and synonyms associated with Topoisomerase II alpha (TOP2A)

  • DNA topoisomerase II, alpha isozyme (TOP2A) antibody
  • DNA topoisomerase II, alpha isozyme (Bm1_08705) antibody
  • topoisomerase (DNA) II alpha (Top2a) antibody
  • topoisomerase (DNA) II alpha 170kDa (TOP2A) antibody
  • topoisomerase (DNA) II beta (Top2b) antibody
  • topoisomersae II (TOPOII) antibody
  • D230016L12Rik antibody
  • TOP-2 antibody
  • TOP2 antibody
  • TOP2A antibody
  • TP2A antibody

Protein level used designations for TOP2A

DNA topoisomerase II, alpha isozyme , DNA Topoisomerase II alpha , DNA topoisomerase 2-alpha , topoisomerase (DNA) 2 alpha , DNA gyrase , DNA topoisomerase (ATP-hydrolyzing) , DNA topoisomerase II, 170 kD , DNA topoisomeraseII_alpha , DNA topoisomerase 2-beta , DNA topoisomerase II, beta isozyme

700707 Macaca mulatta
6096668 Brugia malayi
21973 Mus musculus
360243 Rattus norvegicus
100689304 Cricetulus griseus
7153 Homo sapiens
480525 Canis lupus familiaris
395570 Gallus gallus
787696 Bos taurus
21974 Mus musculus
396917 Sus scrofa
Selected quality suppliers for anti-Topoisomerase II alpha (TOP2A) Antibodies
Did you look for something else?